Summary
Support for the advanced development of novel therapeutic candidates for biodefense pathogens or emerging infectious diseases, specifically focusing on Melioidosis.
Development of a Novel Therapeutic for Melioidosis
US · IL
NIH
grant
open
#nih-75N93022C00059-P00008-9999-1
What they want
The research and development activities will advance therapeutic product development, encompassing lead optimization, candidate selection, preclinical and IND enabling studies, Chemistry, Manufacturing, and Controls (CMC), IND submission, and clinical safety and efficacy assessment.
Deliverables
- Lead optimization
- Candidate selection
- Preclinical and IND enabling studies
- Chemistry, Manufacturing, and Controls (CMC)
- IND submission
- Clinical safety and efficacy assessment
